Dorman Products (NASDAQ: DORM) reported Q1 EPS of $0.56, $0.36 worse than the analyst estimate of $0.92. Revenue for the quarter came in at $466.7 million versus the consensus estimate of $480.89 million.

GUIDANCE:

Dorman Products sees FY2023 EPS of $5.15-$5.35, versus the consensus of $5.20. Dorman Products sees FY2023 revenue of $1.95-2 billion, versus the consensus of $2 billion.

For earnings history and earnings-related data on Dorman Products (DORM) click here.